Distinct vulnerability and resilience of human neuroprogenitor subtypes in cerebral organoid model of prenatal hypoxic injury
No serious systemic ghk-cu side effects have been documented in peer-reviewed human studies at therapeutic doses
There is few clinical evidence of the effect of agomelatine in reducing overall depressive symptoms: results show agomelatine's higher response and lower remission rate compared to placebo ( The knowledge of clinical use of melatonin is growing, with evidence supporting the prescription of exogenous melatonin for a few clinical situations
Epithalon for longevity and sleep Epithalon is a synthetic version of epithalamin, a peptide produced by the pineal gland
This overlap makes determining whether observed cases represent a true drug effect or reflect underlying patient susceptibility challenging
Future work may consider the use of 1) a higher dosage of ALCA, 2) smaller test meals, and 3) the use of metabolically normal test subjects in order to further determine the potential antioxidant benefits of ALCA in relation to postprandial oxidative stress and associated biomarkers
